Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Nils U. Bang"'
Autor:
Nils U. Bang, Marge L. Chang
Publikováno v:
Seminars in Thrombosis and Hemostasis. 1:91-128
Autor:
Nils U. Bang, De Juran Richardson, Joseph P. McConnell, Askiel Bruno, Philip B. Gorelick, Gretchen E. Tietjen, Stanley N. Cohen
Publikováno v:
Thrombosis Research. 115:73-77
Department of Neurology, Indiana University School of Medicine, 541 Clinical Drive, Room 292, Indianapolis, IN 46202-5111, USA Mayo Clinic, Rochester, MN, USA Cedars Sinai Medical Center, Los Angeles, CA, USA Medical College of Ohio, Toledo, OH, USA
Autor:
Askiel Bruno, José Biller, James D. Fleck, James F. Meschia, Lynn A. Cheryk, Nils U. Bang, André Durocher, Joseph P. McConnell, Linda S. Williams
Publikováno v:
Neuroscience Letters. 313:88-92
The aim of this study was to determine the extent of change in platelet and coagulation markers in the acute phase of ischemic stroke and to assess the utility of marker measurement in stroke subtype classification. Urinary 11-dehydro-thromboxane B(2
Publikováno v:
Circulation. 102:1107-1113
Background —Although thrombus formation plays a major role in acute coronary syndromes, few studies have evaluated a thrombus marker in risk stratification of patients with chest pain. Furthermore, the relation between markers that reflect myocardi
Autor:
David Wilson, Nils U. Bang
Publikováno v:
ACC Current Journal Review. 8:13-16
Publikováno v:
Blood. 84:3700-3708
Bovine vascular smooth muscle cells (SMC) express the urokinase-type plasminogen activator receptor (u-PAR) claimed to be important in cell invasion. Receptor numbers and affinity are regulated by thrombin and several other mitogens involved in SMC p
Autor:
Nils U. Bang, Michael D. Clayman
Publikováno v:
Trends in cardiovascular medicine. 2(5)
The introduction of thrombolytic agents and adjunctive anticoagulant therapy in acute myocardial infarction and heparin-aspirin combinations in unstable angina have resulted in major gains in the acute management of these disorders; however, it is wi
Publikováno v:
Biochemical Journal. 295:131-140
Thrombomodulin (TM) is an endothelial cell thrombin receptor that converts thrombin from a procoagulant to an anticoagulant enzyme. It has previously been shown that TM is expressed in both a high-M(r) form containing chondroitin sulphate and a low-M
Publikováno v:
Arteriosclerosis and Thrombosis: A Journal of Vascular Biology. 13:1119-1123
Two glycoforms of recombinant human thrombomodulin (TM; TMD1-105 and TMD1-75), an endothelial cell membrane protein, were tested for their ability to alter thrombin-induced activation of cultured human umbilical vein endothelial cells (HUVECs). After
Publikováno v:
New England Journal of Medicine. 327:755-759
Deposition of fibrin in glomeruli and renal failure are characteristic features of the hemolytic uremic syndrome. An inhibitor of glomerular fibrinolysis has been detected in plasma from children with this disorder. In this study, we define the inhib